Table 1 Clinical and pathological patient characteristics (n = 103)
Clinical/ patholigical features | n | |
|---|---|---|
Age, years (range) | 65 (32–91) | |
Follow up, months (st. dev) | 33 (± 15, 2) | |
Pathological tumor stage | ||
pT1a | 27, (26, 2%) | |
pT1b | 28 (27, 2%) | |
pT2 | 11 (10, 7%) | |
pT3a | 7 (6, 8%) | |
pT3b | 28 (27, 2%) | |
pT3c | 2 (1, 9%) | |
Grading | ||
1 | 12 (11, 7%) | |
2 | 69 (66, 9%) | |
3 | 22 (21, 4%) | |
Metastasis at time of surgery | ||
No | 88 (84, 5%) | |
Yes | 16 (15, 5%) | |
Surgery | ||
nephron sparing | 26 (25, 2%) | |
pT1a | 67% (18 of 27 patients) | |
pT1b | 29% (8 of 28 patients) | |
pT2-3c | 0% (0 of 48 patients) | |
nephrectomy | 77 (74, 8%) | |
Clinical failure | ||
No | 82 (79, 6%) | |
Yes | 21 (20, 4%) | |
Cancer related death | ||
No | 87 (84, 5%) | |
Yes | 16 (15, 5%) | |